Matthew Gall
Overview
Matthew Gall received an average of $2M in total compensation, including $333K in salary, at iTeos Therapeutics between 2020 and 2023.
Source: SEC filings on April 25, 2024 and May 5, 2021.
Related executives
We found three more executives who work or worked at iTeos Therapeutics.